Plant Extract Composition for Statin-Free Cholesterol Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current pharmacological treatments for hypercholesterolemia, such as statins, have significant side effects and are not suitable for all patients, particularly those resistant or intolerant to statins, and there is a need for alternative strategies to manage mild or moderate cardiovascular risk factors.

Innovation Solution

A composition comprising extracts from the genus Malus, Olea Europaea, and policosanols, which synergistically reduce plasma cholesterol levels, increase HDL levels, and decrease lipid peroxidation, providing a safe and effective alternative to statins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If statins are used to reduce LDL levels, then cholesterol reduction is achieved, but side effects occur in muscles and liver

Engineering Contradiction:
ImproveLDL cholesterol levelsVSAvoidside effects (myopathies, rhabdomyolysis, liver impairment)
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent replaces long-term statin therapy with a natural compound composition that achieves cholesterol reduction without the cumulative toxic effects of pharmaceutical statins. The composition uses naturally occurring substances (polysaccharides, polyphenols, sterols) that are metabolized and eliminated without persistent harmful accumulation in muscles and liver.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The invention employs a composite composition containing multiple natural components (polysaccharides from Malus genus, polyphenols from Olea europaea, and plant sterols) that work synergistically to reduce cholesterol. This composite approach provides efficacy similar to statins while avoiding their harmful side effects through the use of biocompatible natural substances.

Inventive Principle:
Principle #40Composite materials

2Reliability

If statins are prescribed to high-risk patients, then cardiovascular risk is reduced, but treatment resistance and intolerance develop

Engineering Contradiction:
Improvecardiovascular risk reductionVSAvoidtreatment resistance and intolerance
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical and biological parameters of the treatment by replacing synthetic statins with natural compounds having different molecular structures and mechanisms of action. The composition contains polysaccharides, polyphenols, and sterols that interact with cholesterol metabolism through pathways different from HMG-CoA reductase inhibition, thereby avoiding resistance development associated with statin polymorphisms.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The natural composition leverages the body's own metabolic pathways and natural regulatory mechanisms to reduce cholesterol. The plant-derived compounds work with endogenous systems rather than forcing external chemical interventions, reducing the likelihood of immune-mediated intolerance and resistance phenomena.

Inventive Principle:
Principle #25Self-service

3Ease of operation

If lifestyle changes are recommended for mild-risk patients, then intervention is avoided, but cholesterol levels remain uncontrolled

Engineering Contradiction:
Improvelifestyle modificationVSAvoidcholesterol levels
Core Design Contradiction:
Ease of operationVSQuantity of substance

Solution Approach 1:

The patent provides a natural composition that can be incorporated into daily diet or taken as supplements, offering an easy-to-administer solution that bridges between lifestyle changes and pharmaceutical intervention. The composition uses readily available natural substances that do not require complex administration protocols.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Data Source

PatentEP4058040B1Composition for reducing cardiovascular risk
Publication Date: 2026.01.07 NEILOS SRL

AI summary

The present invention relates to a composition comprising an extract of a plant belonging to the genus Malus, an extract of Olea Europaea and policosanols and to the use thereof in reducing plasma cholesterol levels and cardiovascular risk.